Sio Gene Therapies SIOX

Quarterly report 2023-Q3
added 05-16-2026

Sio Gene Therapies EV/EBITDA Ratio 2011-2026 | SIOX

Annual EV/EBITDA Ratio Sio Gene Therapies

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.687	2.28	-0.239	-0.0527	-0.358	-5.65	-70.2	-77.1	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.28	-77.1	-18.8